Table 7.
Outcomes in patients with BMI >40, CCI > 3.
Outcome & narcotic usage | Liposomal bupivacaine PAI | No PAI | P value |
---|---|---|---|
Length of stay (d) | 4 | 3 | 0.391 |
Narcotic use 0-24 h (mg) | 77.25 | 119.67 | 0.618 |
Narcotic use 24-48 h (mg) | 67.5 | 154.67 | 0.254 |
Narcotic use 48-72 h (mg) | 30 | 125 | 0.237 |
Walking distance POD 1 (ft) | 24.33 | 3 | 0.472 |
Walking distance POD 2 (ft) | 47.67 | 11 | 0.28 |
POD, postoperative day; PAI, periarticular injection; BMI, body mass index; CCI, Charlson comorbidity index.